Inventor · disambiguated record
Yutong Jiang
Also filed as: JIANG YUTONG
68 granted patents·18 pending applications·1,207 citations·filing 2005–2023
99Inventor score
Top patents by PatentIndex Score
86 records- 0199US9676783B2Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2015·Granted Jun 13, 2017·23 cites·83 claims
- 0299US9127013B2Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2015·Granted Sep 8, 2015·47 cites·30 claims
- 0399US8865698B2Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2013·Granted Oct 21, 2014·45 cites·33 claims
- 0498US10174028B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·14 cites·29 claims
- 0598US10174027B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jan 8, 2019·17 cites·30 claims
- 0698US10138243B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·14 cites·29 claims
- 0798US10112942B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 30, 2018·29 cites·30 claims
- 0898US9493476B2Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Nov 15, 2016·46 cites·14 claims
- 0998US9447104B2Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2014·Granted Sep 20, 2016·21 cites·92 claims
- 1098US7491794B2Macrocyclic compounds as inhibitors of viral replicationINTERMUNE INC·Filed 2005·Granted Feb 17, 2009·147 cites·1 claims
- 1197US10953005B1Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·16 claims
- 1297US10137124B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Nov 27, 2018·12 cites·29 claims
- 1397US10047097B2Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2018·Granted Aug 14, 2018·9 cites·22 claims
- 1497US10023570B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jul 17, 2018·14 cites·103 claims
- 1597US10005783B2Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 26, 2018·10 cites·140 claims
- 1697US9902741B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 27, 2018·22 cites·15 claims
- 1797US9840519B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 12, 2017·21 cites·5 claims
- 1897US9750744B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Sep 5, 2017·21 cites·29 claims
- 1997US9718822B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Aug 1, 2017·22 cites·15 claims
- 2097US8791123B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsALLEN SHELLEY·Filed 2010·Granted Jul 29, 2014·94 cites·61 claims
- 2197US8513263B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsHAAS JULIA·Filed 2009·Granted Aug 20, 2013·110 cites·30 claims
- 2296US10172851B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·8 cites·29 claims
- 2396US9796724B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·16 cites·30 claims
- 2496US9782415B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 10, 2017·19 cites·30 claims
- 2595US9796723B2Method of treatment using substituted imidazo[1,2b]pyridazine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·15 cites·30 claims
- 2695US9795611B2Method of treatment using substituted imidazo[1,2b]pyridazine compoundsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·15 cites·30 claims
- 2795US9682979B2Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 20, 2017·27 cites·43 claims
- 2895US8933084B2Macrocyclic compounds as Trk kinase inhibitorsANDREWS STEVEN WADE·Filed 2011·Granted Jan 13, 2015·113 cites·52 claims
- 2995US8450322B2Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitorsANDREWS STEVEN D·Filed 2009·Granted May 28, 2013·93 cites·24 claims
- 3094US10555944B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Feb 11, 2020·10 cites·12 claims
- 3194US8299021B2Macrocyclic inhibitors of hepatitis C virus replicationBLATT LAWRENCE M·Filed 2012·Granted Oct 30, 2012·47 cites·2 claims
- 3293US10647730B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted May 12, 2020·4 cites·15 claims
- 3393US10011604B2Method of treatment using substituted imidazo[1,2b]pyridazine compoundsARRAY BIOPHARMA INC·Filed 2015·Granted Jul 3, 2018·9 cites·18 claims
- 3493US7829665B2Macrocyclic inhibitors of hepatitis C virus replicationINTERMUNE INC·Filed 2006·Granted Nov 9, 2010·27 cites·29 claims
- 3592US10584124B2Crystalline formsARRAY BIOPHARMA INC·Filed 2018·Granted Mar 10, 2020·12 cites·9 claims
- 3691US10172845B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Jan 8, 2019·4 cites·29 claims
- 3789US11634417B2Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Granted Apr 25, 2023·2 cites·52 claims
- 3889US10144734B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Dec 4, 2018·6 cites·30 claims
- 3989US9227975B2Method of treatment using substituted imidazo[1,2B]pyridazine compoundsANDREWS STEVEN W·Filed 2012·Granted Jan 5, 2016·12 cites·26 claims
- 4088US10441581B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted Oct 15, 2019·2 cites·29 claims
- 4188US10251889B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Apr 9, 2019·4 cites·18 claims
- 4287US11998545B2Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Granted Jun 4, 2024·0 cites·14 claims
- 4387US9878997B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jan 30, 2018·4 cites·10 claims
- 4487US9562055B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsALLEN SHELLEY·Filed 2012·Granted Feb 7, 2017·8 cites·61 claims
- 4586US2024132500A1Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 4684US2023234955A1Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compoundsARRAY BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4782US10881652B2Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Jan 5, 2021·2 cites·14 claims
- 4882US10323022B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 18, 2019·2 cites·26 claims
- 4980US2023090520A1Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitorsARRAY BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 5079US2024124453A1Protein tyrosine phosphatase inhibitorsARRAY BIOPHARMA INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 86 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yutong Jiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →